Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-012415
Filing Date
2018-05-10
Accepted
2018-05-10 18:04:57
Documents
1
Period of Report
2018-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4047
  Complete submission text file 0000899243-18-012415.txt   5451
Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Issuer) CIK: 0001694665 (see all company filings)

EIN.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVELO BIOSCIENCES, INC. 620 MEMORIAL DRIVE, SUITE 200 CAMBRIDGE MA 02139
Business Address
Bodmer Mark (Reporting) CIK: 0001738885 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38473 | Film No.: 18824361